Revenue Of The Cell Line Development Industry Is Set To Reach US$ 8.2 Billion By 2033

Posted on 2023-06-23 by Fact.MR in Healthcare // 0 Comments

Rockville, US, 2023-Jun-23 — /EPR Network/ —

The value of the global cell line development market stands at US$ 4.97 billion in 2023 and is projected to reach a valuation of US$ 8.2 billion by the end of 2033. Over the next ten years, Fact.MR’s research projects global demand for cell line development to rise at 5.1% CAGR.

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global Cell Line Development market. The report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth.

Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the report elaborates the market behavior of each vendor operating in the Cell Line Development market.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=180

Key findings of the Cell Line Development market study:

Regional breakdown of the Cell Line Development market based on predefined taxonomy.
Innovative manufacturing processes implemented by Cell Line Development vendors in detail.
Region-wise and country-wise fragmentation of the Cell Line Development market to grasp the revenue, and growth outlook in these areas.
Changing preferences among consumers across various regions and countries.
Factors (Positive and Negative) impacting the growth of the global Cell Line Development market.

Key Companies Profiled

Thermo Fisher Scientific Inc.
WuXi AppTec Co. Ltd.
Corning Incorporated
Selexis SA
Sigma-Aldrich Corporation
Sartorius AG
General Electric Company
Lonza Group Ltd.
Abzena plc.
American Type Culture Collection Inc.

Competitive Landscape

Leading cell line development providers are focusing on research and development of unique approaches that could aid in the creation of better and more effective cell therapies to treat various diseases.

In January 2023, Berkeley Lights Inc., a leading life sciences tools provider, announced the launch of a new optofluidic system for cell line development. The Beacon Select™ system is based on the same technology that its predecessor was launched with back in 2017.

Key Segments of Cell Line Development Industry Research

By Product Type :
- Immunotherapy Cell Lines
- Ion Channel Cell Lines
- GPCR Cell Lines
- Cell Signaling Pathway Cell Lines
- Gene Knockout Cell Lines
- Cancer Cell Lines
- Other
By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA

Get Full Access of the Complete Report:
https://www.factmr.com/checkout/180

Queries addressed in the Cell Line Development market report:

Why are the Cell Line Development market players targeting region for increased product sales?
What patented technologies are the players utilizing in the global Cell Line Development market?
Which regions are displaying the fastest growth in the Cell Line Development market?
What are the underlying micro- macroeconomic factors affecting the global Cell Line Development market?

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Matched content

Editor’s pick